Related Experiment Video
Updated: May 8, 2026
08:21
Monitoring GPCR-β-arrestin1/2 Interactions in Real Time Living Systems to Accelerate Drug Discovery
Published on: June 28, 2019
Are GPCRs still a source of new targets?
11NQuiX Ltd, Stevenage Bioscience Catalyst, Stevenage SG1 2FX, UK.
Journal of Biomolecular Screening
|August 16, 2013
Summary
G-protein-coupled receptors (GPCRs) represent vast untapped therapeutic potential beyond current aminergic targets. Advances in pharmacology and technology are enabling exploration of previously undrugged GPCRs for novel disease treatments.
Area of Science:
- Pharmacology
- Drug Discovery
- Molecular Biology
Background:
- G-protein-coupled receptors (GPCRs) are a large family of cell surface receptors with significant therapeutic potential, yet current drugs primarily target a small subset (aminergic receptors).
- Progress in targeting other GPCR subfamilies, including orphans and various families (A, B, C, F), has been limited due to receptor heterogeneity and challenges in drug discovery.
- Growing evidence links numerous undrugged GPCRs to a wide spectrum of diseases, highlighting the need for expanded therapeutic strategies.
Purpose of the Study:
- To review the current landscape of GPCR drug discovery, emphasizing the untapped potential beyond aminergic targets.
- To discuss the challenges and limitations hindering the development of therapeutics for diverse GPCR subfamilies.
- To highlight emerging scientific and technical advancements that facilitate the exploration of novel GPCR targets and drug mechanisms.
Main Methods:
- Review of existing literature on GPCR pharmacology and drug discovery.
- Analysis of current trends in screening technologies, structural biology (X-ray crystallography), and ligand design.
- Exploration of novel therapeutic strategies, including allosteric modulation, biased agonism, and GPCR-protein complexes.
Main Results:
- Despite limitations, significant opportunities exist for developing therapeutics targeting under-explored GPCRs.
- Advances in structural biology and screening methods are improving the identification and characterization of GPCR ligands.
- Emerging strategies like allosteric modulation and biased signaling offer potential for more refined and effective GPCR-targeted drugs.
Conclusions:
- The GPCR field holds immense promise for novel drug development, extending far beyond currently targeted receptors.
- Technical innovations and a deeper understanding of GPCR signaling mechanisms are crucial for unlocking the therapeutic potential of undrugged GPCRs.
- Future drug discovery efforts should leverage advanced techniques and explore diverse pharmacological approaches to address a broader range of diseases through GPCR modulation.
More Related Videos
Related Concept Videos
01:30Transducer Mechanism: G Protein–Coupled Receptors
G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical, 7TM, or...
GPCRs are also called heptahelical, 7TM, or...
01:15G Protein-coupled Receptors
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
01:15G Protein-coupled Receptors
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:21G-protein Coupled Receptors
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
01:21G-protein Coupled Receptors
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.